CCN2 and pancreatic neoplasm: FG-3019 is a human anti-CTGF IgG1 monoclonal antibody currently under clinical investigation as a potential therapeutic for treatment of idiopathic pulmonary fibrosis, liver fibrosis and pancreatic cancer (5).